Alterations of high-density lipoprotein subclasses in hypercholesterolemia and combined hyperlipidemia

International Journal of Cardiology

Volumn 120, Issue 3, 2007, Pages 331-337

  Jia, Lianqun ^a   Fu, Mingde ^a   Tian, Ying ^b   Xu, Yanhua ^c   Gou, Lantu ^a   Tian, Haoming ^a   Tian, Li ^a  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

^c Hoist Group Postdoctoral Work Station   (China)

Author keywords

2 Dimensional gel electrophoresis immunodetection; Combined hyperlipidemia; HDL subclasses; Hypercholesterolemia

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN 2A; HIGH DENSITY LIPOPROTEIN 2B; HIGH DENSITY LIPOPROTEIN 3A; HIGH DENSITY LIPOPROTEIN 3B; HIGH DENSITY LIPOPROTEIN 3C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PRE BETA1 HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DYSLIPOPROTEINEMIA; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; AGED; APOLIPOPROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIAS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 34447531784     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.10.007     Document Type: Article

References (41)

1. Johnsen S.H., Mathiesen E.B., and Fosse E. Elevated high-density lipoprotein cholesterol levels are protective against plaque progression: a follow-up study of 1952 persons with carotid atherosclerosis The Tromsø Study. Circulation 112 (2005) 498-504
2. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults: executive summary of the third report of the National Cholesterol Education Program(NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults(Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
3. Ballantyne C., Arroll B., and Shepherd J. Lipids and CVD management: towards a global consensus. Eur Heart J 26 (2005) 2224-2231
4. Kwiterovich Jr. P.O. The antiatherogenic role of high-density lipoprotein cholesterol. Am J Cardiol 82 (1998) 13Q-21Q
5. Goldbourt U., Yaari S., and Medalie J.H. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality: a 21-year follow-up of 8000 men. Arterioscler Thromb Vasc Biol 17 (1997) 107-113
6. Hill S.A., and McQueen M.J. Reverse cholesterol transport - a review of the process and its clinical implications. Clin Biochem 30 (1997) 517-525
7. von Eckardstein A., Huang Y., and Assmann G. Physiological role and clinical relevance of high-density lipoprotein subclasses. Curr Opin Lipidol l5 (1994) 404-416
8. Wu X., Fu M., and Liu B. Study on the immunodetection method of HDL subclasses in human serum. Chin J Arterioscler 7 (1999) 253-255
9. Silverman D.I., Geoffery S.G., and Pasternak R.C. High-density lipoprotein subfractions. Am J Med 94 (1993) 636-645
10. Sviridov D., and Nestel P. Dynamics of reverse cholesterol transport: protection against atherosclerosis. Atherosclerosis 161 (2002) 245-254
11. Stein O., and Stein Y. Atheroprotective mechanisms of HDL. Atherosclerosis 144 (1999) 285-301
12. Asztalos B., Zhang W., Roheim P.S., and Wong L. Role of free apolipoprotein A-I in cholesterol efflux. Formation of pre-alpha-migrating high-density lipoprotein particles. Arterioscler Thromb Vasc Biol 17 (1997) 1630-1636
13. Johansson J., Carlson L.A., Landou C., and Hamsten A. High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb 11 (1991) 174-182
14. Cheung M.C., Brown B.G., and Wolf A.C. Altered particle size distribution of apoA-I-containing HDL subpopulations in patients with coronary heart disease. J Lipid Res 32 (1991) 383-394
15. Asztalos B.F., Collins D., Cupples L.A., et al. Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial. Arterioscler Thromb Vasc Biol 25 (2005) 2185-2191
16. Rosenson R.S., Otvos J.D., and Freedman D.S. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. Am J Cardiol 90 (2002) 89-94
17. Asztalos B.F., Cupples L.A., Demissie S., et al. High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 24 (2004) 2181-2187
18. Lindbohm N., Gylling H., Miettinen T.E., and Miettinen T.A. Sialic acid content of LDL and lipoprotein metabolism in combined hyperlipidemia and primary moderate hypercholesterolemia. Clin Chim Acta 285 (1999) 69-84
19. Gou L., Fu M., Xu Y., Tian Y., Yan B., and Yang L. Alterations of HDL subclasses in endogenous hypertriglyceridemia. Am Heart J 150 (2005) 1039-1045
20. Warnick G.R., Nguyen T., and Albers A.A. Comparison of improved precipitation methods for quantification of high-density lipoprotein cholesterol. Clin Chem 31 (1985) 217-222
21. Friedwald W.F., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
22. Labeur C., Shepherd J., and Rosseneu M. Immunological assays of apolipoproteins in plasma: methods and instrumentation. Clin Chem 36 (1990) 591-597
23. Liu B. Immunoassay of human plasma apolipoproteins and clinical applications. In: Wang K.Q. (Ed). Lipoproteins and atherosclerosis (1995), People's Health Press, Beijing 359-368
24. Jia L., Bai H., Fu M., Xu Y., Yang Y., and Long S. Relationship between plasma HDL subclasses distribution and apoA-I gene polymorphisms. Clin Chim Acta 360 (2005) 37-45
25. Long S., Tian Y., Zhang R., et al. Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia. Clin Chim Acta 366 (2006) 316-321
26. Dobiasova M., and Frohlich J. Understanding the mechanism of LCAT reaction may help to explain the high predictive value of LDL/HDL cholesterol ratio. Physiol Res 47 (1998) 387-397
27. Sasahara T., Nestel P., Fidge N., and Sviridov D. Cholesterol transport between cells and high density lipoprotein subfractions from obese and lean subjects. J Lipid Res 39 (1998) 544-554
28. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
29. Stamler J., Wentworth D., and Neaton J.D. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 256 (1986) 2823-2828
30. Applebaun-Bowden D. Lipases and lecithin:cholesterol acyltransferase in the control of lipoprotein metabolism. Curr Opin Lipidol 6 (1995) 130-135
31. Bagdade J.D., Ritter M.C., and Subbaiah P.V. Accelerated cholesteryl ester transfer in plasma of patients with hypercholesterolemia. J Clin Invest 87 (1991) 1259-1265
32. Inazu A., Koizumi J., Mabuchi H., Kajinami K., and Takeda R. Enhanced cholesteryl ester transfer protein activities and abnormalities of high density lipoproteins in familial hypercholesterolemia. Horm Metab Res 24 (1992) 284-288
33. Rye K.A., Clay M.A., and Barter P.J. Remodeling of high density lipoproteins by plasma factors. Atherosclerosis 145 (1999) 227-238
34. Saidi Y., Sich D., Camproux A., et al. Interrelationships between postprandial lipoprotein B: CIII particle changes and high-density lipoprotein subclass profiles in mixed hyperlipoproteinemia. Metabolism 48 (1999) 60-67
35. Miida T., Kawano M., Fielding C.J., and Fielding P.E. Regulation of the concentration of pre-β high-density lipoprotein in normal plasma by cell membranes and lecithin: cholesterol acyltransferase activity. Biochemistry 31 (1992) 11112-11117
36. Miida T., Yamaguchi T., Tsuda T., and Okada M. High prebeta1-HDL levels in hypercholesterolemia are maintained by probucol but reduced by a low-cholesterol diet. Atherosclerosis 138 (1998) 129-134
37. Quintao E.C. Is reverse cholesterol transport a misnomer for suggesting its role in the prevention of atheroma formation?. Atherosclerosis 116 (1995) 1-14
38. Kwiterovich Jr. P.O. The Metabolic pathways of high-density lipoprotein, low-density lipoprotein and triglycerides: a current review. Am J Cardiol 86 (2000) 5L-10L
39. Rizzo M., and Berneis K. Low-density lipoprotein size and cardiovascular risk assessment. QJM 99 (2006) 1-14
40. Brunzell J.D., Albers J.J., Chait A., Grundy S.M., Groszek E., and McDonald G.B. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res 24 (1983) 147-155
41. Tato F., Vega G.L., and Tall A.R. Relation between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia. Arterioscler Thromb Vasc Biol 15 (1995) 112-120